Cancer cell therapy study pulled before it began
Disease control
Terminated
This study was designed to test an experimental treatment called GT316, which uses a patient's own immune cells (tumor-infiltrating lymphocytes) to fight advanced gynecological tumors. The goal was to see if the therapy was safe and could shrink tumors. However, the study was wit…
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 17, 2026 02:56 UTC